SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-23-000031
Filing Date
2023-04-19
Accepted
2023-04-19 18:06:07
Documents
1
Period of Report
2023-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168194195395803.html 4  
1 FORM 4 wf-form4_168194195395803.xml 4 3862
  Complete submission text file 0001689375-23-000031.txt   5250
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Sethuraman Natarajan (Reporting) CIK: 0001873394 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 23830962